Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M500427-JLR200 on December 4, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M500427-JLR200v1
47/3/582    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marschall, H.-U.
Right arrow Articles by Trauner, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marschall, H.-U.
Right arrow Articles by Trauner, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 47, 582-592, March 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology

Fxr–/– mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids

Hanns-Ulrich Marschall1,*, Martin Wagner{dagger}, Karl Bodin§, Gernot Zollner{dagger}, Peter Fickert{dagger}, Judith Gumhold{dagger}, Dagmar Silbert{dagger}, Andrea Fuchsbichler{dagger}, Jan Sjövall§ and Michael Trauner{dagger}

* Karolinska Institutet, Department of Medicine at Karolinska University Hospital Huddinge, S-14186 Stockholm, Sweden
{dagger} Laboratory of Experimental and Molecular Hepatology, Department of Internal Medicine, Medical University, A-8036 Graz, Austria
§ Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-17177 Stockholm, Sweden

Published, JLR Papers in Press, December 4, 2005.

1 To whom correspondence should be addressed. e-mail: hanns-ulrich.marschall{at}medhs.ki.se

Farnesoid X receptor knockout (Fxr–/–) mice cannot upregulate the bile salt export pump in bile acid loading or cholestatic conditions. To investigate whether Fxr–/– mice differ in bile acid detoxification compared with wild-type mice, we performed a comprehensive analysis of bile acids extracted from liver, bile, serum, and urine of naive and common bile duct-ligated wild-type and Fxr–/– mice using electrospray and gas chromatography mass spectrometry. In addition, hepatic and renal gene expression levels of Cyp2b10 and Cyp3a11, and protein expression levels of putative renal bile acid-transporting proteins, were investigated. We found significantly enhanced hepatic bile acid hydroxylation in Fxr–/– mice, in particular hydroxylations of cholic acid in the 1ß, 2ß, 4ß, 6{alpha}, 6ß, 22, or 23 position and a significantly enhanced excretion of these metabolites in urine. The gene expression level of Cyp3a11 was increased in the liver of Fxr–/– mice, whereas the protein expression levels of multidrug resistance-related protein 4 (Mrp4) were increased in kidneys of both genotypes during common bile duct ligation. In conclusion, Fxr–/– mice detoxify accumulating bile acids in the liver by enhanced hydroxylation reactions probably catalyzed by Cyp3a11. The metabolites formed were excreted into urine, most likely with the participation of Mrp4.

Supplementary key words farnesoid X receptor knockout • multidrug resistance-related protein 4 • cytochrome 3a11 • gas chromatography-mass spectrometry • electrospray mass spectrometry

Abbreviations: Asbt, apical sodium-dependent bile acid transporter; Bsep, bile salt export pump; CA, cholic acid; CBDL, common bile duct ligation; DCA, deoxycholic acid; ES-MS, electrospray mass spectrometry; FXR, farnesoid X receptor; LCA, lithocholic acid; MCA, muricholic acid; MeTMS, methyl ester trimethylsilyl ether; Mrp, multidrug resistance-related protein; Oatp1, organic anion-transporting polypeptide 1; PXR, pregnane X receptor; RI, retention index; UDCA, ursodeoxycholic acid


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
P. Fickert, A. Fuchsbichler, T. Moustafa, M. Wagner, G. Zollner, E. Halilbasic, U. Stoger, M. Arrese, M. Pizarro, N. Solis, et al.
Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts
Am. J. Pathol., December 1, 2009; 175(6): 2392 - 2405.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. A. Gyamfi and Y.-J. Y. Wan
Mechanisms of Resistance of Hepatocyte Retinoid X Receptor {alpha}-Null Mice to WY-14,643-induced Hepatocyte Proliferation and Cholestasis
J. Biol. Chem., April 3, 2009; 284(14): 9321 - 9330.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
Y. Alnouti
Bile Acid Sulfation: A Pathway of Bile Acid Elimination and Detoxification
Toxicol. Sci., April 1, 2009; 108(2): 225 - 246.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Klein, G. A. Kullak-Ublick, M. Wagner, M. Trauner, and J. J. Eloranta
Hepatocyte nuclear factor-4{alpha} and bile acids regulate human concentrative nucleoside transporter-1 gene expression
Am J Physiol Gastrointest Liver Physiol, April 1, 2009; 296(4): G936 - G947.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Physiol Rev, January 1, 2009; 89(1): 147 - 191.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
X. Cheng and C. D. Klaassen
Perfluorocarboxylic Acids Induce Cytochrome P450 Enzymes in Mouse Liver through Activation of PPAR-{alpha} and CAR Transcription Factors
Toxicol. Sci., November 1, 2008; 106(1): 29 - 36.
[Abstract] [Full Text] [PDF]

Home page
 Exp Biol MedHome page
T. Wada, H. S. Kang, A. M. Jetten, and W. Xie
The Emerging Role of Nuclear Receptor ROR{alpha} and Its Crosstalk with LXR in Xeno- and Endobiotic Gene Regulation
Exp Biol Med, October 1, 2008; 233(10): 1191 - 1201.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Stedman, C. Liddle, S. Coulter, J. Sonoda, J. G. Alvarez, R. M. Evans, and M. Downes
Benefit of farnesoid X receptor inhibition in obstructive cholestasis
PNAS, July 25, 2006; 103(30): 11323 - 11328.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
G. Kakiyama, T. Iida, T. Goto, N. Mano, J. Goto, T. Nambara, L. R. Hagey, C. D. Schteingart, and A. F. Hofmann
Identification of a novel bile acid in swans, tree ducks, and geese: 3{alpha},7{alpha},15{alpha}-trihydroxy-5{beta}-cholan-24-oic acid
J. Lipid Res., July 1, 2006; 47(7): 1551 - 1558.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement